Speakers

Researchers, clinicians and industry professionals will share a range of perspectives and their latest work into solving IBD.

  • Headshot of Dr. Kenya Honda

    Kenya Honda, MD, PhD

    Keio University School of Medicine

    The Honda lab examines how gut microbiota and their metabolites regulate host physiology, and how they accumulate locally and systemically and influence many aspects of mammalian physiology, including immunity, metabolism and the nervous system.
  • Headshot of Dr. Carrie Lucas

    Carrie Lucas, PhD

    Yale School of Medicine

    The Lucas laboratory uses human genomics, patient-derived cells and mouse models to discover new and translationally relevant principles of immunology starting with patients suffering from diseases of the immune system.
  • Headshot of Dr. Laura Mackay

    Laura Mackay, PhD

    University of Melbourne; Walter and Eliza Hall Institute of Medical Research

    The Mackay lab studies memory T cell responses, focusing on the signals that control tissue-resident memory T cell differentiation, to harness these cells to develop new treatments against infection, cancer and autoimmune conditions.
  • Headshot of Dr. Harmit Malik

    Harmit Malik, PhD

    Fred Hutch Cancer Center

    The Malik lab investigates genetic conflicts between genomes and within genomes. Such conflicts shape innate antiviral immunity and viral genomes over evolution and can be used to deduce design principles to enhance immunity against viruses.
  • Headshot of Dr. James McCluskey

    James McCluskey, PhD

    University of Melbourne, Doherty Institute

    The McCluskey lab focuses on Mucosal Associated Invariant T cells and other MR1-restricted T cells to explore their function, including modes of T cell recognition and new ligands recognized by these T cells in health and disease.
  • Headshot of Dr. Kathy McCoy

    Kathy McCoy, PhD

    University of Calgary

    The McCoy lab studies how early-life exposure to intestinal microbes shapes immune development and affects susceptibility to immune-mediated disease. They also investigate microbiome pathways to inform therapeutic strategies and interventions.
.st6,.st7{fill:#e6e6e5;stroke:#010101;stroke-width:2.5;stroke-miterlimit:10;stroke-linecap:round;stroke-linejoin:round}.st7{fill:none}

Sign Up For Our Newsletter

Stay updated on the Kenneth Rainin Foundation and our grantees.